| 000 | 01722 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516155947.0 | ||
| 264 | 0 | _c20140318 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2013.06.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeng, Taotao | |
| 245 | 0 | 0 |
_aNovel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cSep 2013 |
||
| 300 |
_a5339-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcrylamide _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 |
_aHistone Deacetylase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHistone Deacetylase 6 |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aHistone Deacetylases _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aRecombinant Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aRepressor Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aWang, Hai | |
| 700 | 1 | _aSu, Hong | |
| 700 | 1 | _aLu, Hui | |
| 700 | 1 | _aYu, Liqin | |
| 700 | 1 | _aZhang, Xiaojin | |
| 700 | 1 | _aSun, Haopeng | |
| 700 | 1 | _aYou, Qidong | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 21 _gno. 17 _gp. 5339-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2013.06.009 _zAvailable from publisher's website |
| 999 |
_c22885783 _d22885783 |
||